LogicBio Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 41
Employees
  • Stock Symbol
  • LOGC
Stock Symbol
  • Share Price
  • $5.29
  • (As of Wednesday Closing)

LogicBio Therapeutics General Information

Description

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 610 Main Street
  • 3rd Floor
  • Cambridge, MA 02139
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LogicBio Therapeutics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.29 $5.67 $3.05 - $11.60 $168M 31.7M 175K -$1.75

LogicBio Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 165,156 112,322 250,817
Revenue 1,986 0 0 0
EBITDA (39,386) (40,771) (18,013) (5,744)
Net Income (40,065) (40,128) (17,621) (5,795)
Total Assets 47,343 55,660 82,910 26,174
Total Debt 16,308 10,314 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

LogicBio Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LogicBio Therapeutics‘s full profile, request access.

Request a free trial

LogicBio Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore LogicBio Therapeutics‘s full profile, request access.

Request a free trial

LogicBio Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in
Biotechnology
Cambridge, MA
41 As of 2019
00000
0000 0000-00-00
00000000 00000

00000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000000
Bedford, MA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

0000000

psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000000000000
New York, NY
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LogicBio Therapeutics Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Homology Medicines Formerly VC-backed Bedford, MA 000 00000 00000000 00000
0000000 0000000000 Formerly VC-backed New York, NY 00 00000 00000000 00000
0000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
00000000 000000000 Formerly VC-backed Cambridge, MA 000 0000 000000 - 000 0000
00000000 Formerly VC-backed London, United Kingdom 000 00000 000000000 00000
You’re viewing 5 of 45 competitors. Get the full list »

LogicBio Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Frederic Chereau Chief Executive Officer, President & Board Member
Matthias Jaffe Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Adi Barzel Ph.D Co-Founder
Nelson Chau Ph.D Vice President of Biology & Translational Research
You’re viewing 4 of 6 executive team members. Get the full list »

LogicBio Therapeutics Board Members (10)

Name Representing Role Since
Erez Chimovits LogicBio Therapeutics Board Member 000 0000
Frederic Chereau LogicBio Therapeutics Chief Executive Officer, President & Board Member 000 0000
Leon Chen Ph.D OrbiMed Board Member 000 0000
Leszek Lisowski LogicBio Therapeutics Co-Founder & Board Member 000 0000
Mark Enyedy JD Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

LogicBio Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LogicBio Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LogicBio Therapeutics‘s full profile, request access.

Request a free trial